Drug Profile
Research programme: therapeutic agents - Kuhnil Pharmaceutical
Alternative Names: K-0803; KI 1002; KI 1003; KI 1103; KI 1104; KI 1105; KI-0802; KI-0804; KI-0902; KI-0904; KI-0905; KI-0906; KI-0907; KI-1007; KT 1101Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Kuhnil Pharmaceutical Company
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alopecia; Angina pectoris; Cancer; Eating disorders; Genitourinary disorders; Musculoskeletal disorders
- Discontinued Arthritis; Asthma; Gastrointestinal ulcer; Obesity
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Alopecia in South Korea
- 28 Aug 2020 No recent reports of development identified for research development in Genitourinary-disorders in South Korea
- 28 Aug 2020 No recent reports of development identified for research development in Musculoskeletal-disorders in South Korea (Controlled release)